Stay Connected With Us
Sep 20, 2020 PM EDT
Based on research findings, adding abemaciclib to hormonal therapy decreases the risk of recurrence of cancer by 25 percent in patients with HR+ or high-risk early hormone receptor-positive HER2- or human epidermal growth factor receptor 2 negative o..
Aug 24, 2020 AM EDT
The new convalescent plasma treatment means that people who had COVID-19 and already recovered can already have their blood donated to be used to treat patients currently suffering from the said infectious disease.
